Metraipolis › archive › dc_ea359801d47c

Patient Characteristics and Reasons for Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Retrospective Cohort From a Large Urban HIV Clinic — Europe PMC PMID:41194834

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41194834
DOI
10.7759/cureus.95684
License (as archived)
solo-consultazione
Archived
2026-11-08T23:32:21.828Z
SHA-256 of the archived text
0712efcdf1758fa108448a6b3c85f38d9559017a65dc3d37734bb96722acb379
Stable URL of this page
https://metraipolis.com/documento/dc_ea359801d47c

How to cite

Patient Characteristics and Reasons for Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Retrospective Cohort From a Large Urban HIV Clinic — Europe PMC PMID:41194834 — Europe PMC (en), https://europepmc.org/article/MED/41194834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea359801d47c (Metraipolis archive dc_ea359801d47c, sha256 0712efcdf1758fa108448a6b3c85f38d9559017a65dc3d37734bb96722acb379)
BibTeX
@misc{dcea359801d47c,
  title = {Patient Characteristics and Reasons for Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Retrospective Cohort From a Large Urban HIV Clinic — Europe PMC PMID:41194834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41194834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea359801d47c; sha256 0712efcdf1758fa108448a6b3c85f38d9559017a65dc3d37734bb96722acb379},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41194834. Agents can read the archived copy with the MCP tool read_document.